These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21138727)

  • 1. A high-throughput fluorescence chemical denaturation assay as a general screen for protein-ligand binding.
    Mahendrarajah K; Dalby PA; Wilkinson B; Jackson SE; Main ER
    Anal Biochem; 2011 Apr; 411(1):155-7. PubMed ID: 21138727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Large-Amplitude Breathing Motions in the Interface of FKBP12-Drug Complexes.
    Yang CJ; Takeda M; Terauchi T; Jee J; Kainosho M
    Biochemistry; 2015 Dec; 54(47):6983-95. PubMed ID: 26561008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-timescale dynamics study of FKBP12 along the rapamycin-mTOR binding coordinate.
    Sapienza PJ; Mauldin RV; Lee AL
    J Mol Biol; 2011 Jan; 405(2):378-94. PubMed ID: 21073880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein denaturation and protein:drugs interactions from intrinsic protein fluorescence measurements at the nanolitre scale.
    Gaudet M; Remtulla N; Jackson SE; Main ER; Bracewell DG; Aeppli G; Dalby PA
    Protein Sci; 2010 Aug; 19(8):1544-54. PubMed ID: 20552687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the FKBP.rapamycin.FRB ternary complex.
    Banaszynski LA; Liu CW; Wandless TJ
    J Am Chem Soc; 2005 Apr; 127(13):4715-21. PubMed ID: 15796538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational Entropy of FK506 Binding to FKBP12 Determined by Nuclear Magnetic Resonance Relaxation and Molecular Dynamics Simulations.
    Solomentsev G; Diehl C; Akke M
    Biochemistry; 2018 Mar; 57(9):1451-1461. PubMed ID: 29412644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. II. Dissociation free energies in drug-receptor systems via nonequilibrium alchemical simulations: application to the FK506-related immunophilin ligands.
    Nerattini F; Chelli R; Procacci P
    Phys Chem Chem Phys; 2016 Jun; 18(22):15005-18. PubMed ID: 27193181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and structure-based study of new potential FKBP12 inhibitors.
    Sun F; Li P; Ding Y; Wang L; Bartlam M; Shu C; Shen B; Jiang H; Li S; Rao Z
    Biophys J; 2003 Nov; 85(5):3194-201. PubMed ID: 14581219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR.
    Veverka V; Crabbe T; Bird I; Lennie G; Muskett FW; Taylor RJ; Carr MD
    Oncogene; 2008 Jan; 27(5):585-95. PubMed ID: 17684489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamics.
    Sich C; Improta S; Cowley DJ; Guenet C; Merly JP; Teufel M; Saudek V
    Eur J Biochem; 2000 Sep; 267(17):5342-55. PubMed ID: 10951192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energetic and structural analysis of the role of tryptophan 59 in FKBP12.
    Fulton KF; Jackson SE; Buckle AM
    Biochemistry; 2003 Mar; 42(8):2364-72. PubMed ID: 12600203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Differential Scanning Fluorimetry to Identify Nuclear Receptor Ligands.
    DeSantis KA; Reinking JL
    Methods Mol Biol; 2016; 1443():21-30. PubMed ID: 27246332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifunctional Small-Molecule Ligands of K-Ras Induce Its Association with Immunophilin Proteins.
    Zhang Z; Shokat KM
    Angew Chem Int Ed Engl; 2019 Nov; 58(45):16314-16319. PubMed ID: 31557383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Differential Scanning Fluorometry and Related Technologies in Characterization of Protein-Ligand Interactions.
    Baljinnyam B; Ronzetti M; Yasgar A; Simeonov A
    Methods Mol Biol; 2020; 2089():47-68. PubMed ID: 31773647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput fluorescence polarization method for identification of FKBP12 ligands.
    Bollini S; Herbst JJ; Gaughan GT; Verdoorn TA; Ditta J; Dubowchik GM; Vinitsky A
    J Biomol Screen; 2002 Dec; 7(6):526-30. PubMed ID: 14599350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrocyclic FKBP51 Ligands Define a Transient Binding Mode with Enhanced Selectivity.
    Voll AM; Meyners C; Taubert MC; Bajaj T; Heymann T; Merz S; Charalampidou A; Kolos J; Purder PL; Geiger TM; Wessig P; Gassen NC; Bracher A; Hausch F
    Angew Chem Int Ed Engl; 2021 Jun; 60(24):13257-13263. PubMed ID: 33843131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening Chemoreceptor-Ligand Interactions by High-Throughput Thermal-Shift Assays.
    Ehrhardt MKG; Warring SL; Gerth ML
    Methods Mol Biol; 2018; 1729():281-290. PubMed ID: 29429098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand binding analysis and screening by chemical denaturation shift.
    Schön A; Brown RK; Hutchins BM; Freire E
    Anal Biochem; 2013 Dec; 443(1):52-7. PubMed ID: 23994566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.
    Colucci S; Pagani A; Pettinato M; Artuso I; Nai A; Camaschella C; Silvestri L
    Blood; 2017 Nov; 130(19):2111-2120. PubMed ID: 28864813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rapamycin-binding domain of the protein kinase mammalian target of rapamycin is a destabilizing domain.
    Edwards SR; Wandless TJ
    J Biol Chem; 2007 May; 282(18):13395-401. PubMed ID: 17350953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.